# E-DRUG: TERFENADINE **URL:** https://talk.edrugplus.org/t/e-drug-terfenadine/502 **Category:** e-drug **Created:** [March 17, 1997, 7:46am UTC](https://talk.edrugplus.org/t/e-drug-terfenadine/502 "1997-03-17T07:46:40Z") **Posts on this page:** 1 **Page:** 1
### Author: ![Larry\_D\_Sasich](https://avatars.discourse-cdn.com/v4/letter/l/ea666f/32.png) [@Larry\_D\_Sasich](https://talk.edrugplus.org/u/Larry_D_Sasich) #### Post date: [March 17, 1997, 7:46am UTC](https://talk.edrugplus.org/t/e-drug-terfenadine/502/1 "1997-03-17T07:46:40Z")
Dear Colleagues: In mid-January we posted the notice of the FDA's intention to withdraw approval of terfenadine in the US. SCRIP has recently reported that terfenadine has been suspended in France and Luxembourg (SCRIP No 2210 February 28, 1997 p. 17). March 15, 1997 we received word that terfenadine had also been suspended in Saudi Arabia. The action in France means terfenadine is not sold, in Saudi Arabia the drug can longer be imported into the country. We would be interested in hearing from others about the regulatory status of terfenadine in their countries. If a regulatory action has been taken please make the distinction between suspension of terfenadine's import or suspension of sales at the level of the pharmacy. Best Regards, Larry Larry D. Sasich, Pharm.D., FASHP Public Citizen Health Research Group 1600 20th Street NW Washington, DC 20009, USA Voice: 202-588-7782 FAX: 202-588-7796 E-Mail: lsasich@citizen.org -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.